$CROX

Crocs: Q3 Earnings Snapshot

Crocs Inc. reported Q3 earnings of $216.8 million, or $4.52 per share, exceeding Wall Street expectations of $3.31 per share. Revenue was $1.04 billion, surpassing forecasts of $1 billion. The company projects Q4 earnings of $3.25-$3.45 per share and full-year earnings of $14.45-$14.65 per share.

Original reporting
Published Oct 29, 2026, 11:14 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 11:23 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Crocs: Q3 Earnings Snapshot — source image
Decision brief

The 30-second read

$CROXBullishHigh
01

Why it matters

The earnings beat and raised guidance provide a fresh catalyst that could move the stock in early trading.

02

Market read

First report of Crocs' Q3 earnings with a beat; likely to influence short-term price action.

03

What to watch

Potential supply chain constraints or inventory buildup not discussed in the release.

Relevance 7/10Novelty 8/10Timing: pre-market today

Background

Crocs Inc. (CROX) is a publicly traded footwear company headquartered in Broomfield, Colorado.

Company-level read

Ticker impact

$CROXBullishHigh confidence
Context

Crocs reported Q3 earnings of $4.52 EPS, beating estimates of $3.31 and revenue of $1.04B versus $1.00B forecast.

Expected impact

likely upside as market prices in the earnings beat and raised guidance

Evidence & confidence

Both EPS and revenue exceeded consensus, and FY guidance was raised, providing a clear catalyst for buying.

Market effects

Footwear and consumer discretionary sector may see modest lift from Crocs' beat.

U.S. consumer stocks could benefit in early trading.

Limited to markets tracking U.S. consumer earnings.

Counterpoint

If the beat is already priced in, the stock could face short-term profit taking.

Key entities

  • Crocs Inc.

    Footwear manufacturer reporting Q3 results.

Related articles

$CROXMed

UBS raises Crocs stock price target to $145 on strong results

UBS raised its price target on Crocs (CROX) to $145 from $120, citing strong Q3 results and raised guidance. The stock has surged 26% in a week. UBS noted macro uncertainty but sees balanced risk. Crocs reported adjusted earnings of $3.69 per share and revenue of $1.04B, exceeding expectations. Goldman Sachs also raised its target to $128 but maintained a Sell rating.

$CROXMed

Goldman Sachs raises Crocs stock price target on growth outlook

Goldman Sachs raised its price target on Crocs (CROX) to $128 from $95, citing stronger growth, improved profitability, and a positive outlook. The stock has surged 75.7% year-to-date. Crocs reported stronger-than-expected Q3 results, with adjusted earnings of $3.69 per share and revenue of $1.04 billion, raising its full-year outlook. The HEYDUDE brand showed positive performance after two years of negative results.

$CROXHighAI 9/10

"I thought ugly shoes were a thing of the past"... Crocs shares stage stunning turnaround after plunging 30%

Crocs shares surged 25.54% to $150.26 after strong Q3 results and an upgraded full-year outlook. Adjusted EPS of $3.69 beat estimates, and revenue reached $1.04 billion. HEYDUDE, a subsidiary, saw a 6.1% revenue increase. CEO Andrew Rees cited growth across brands and regions. Last year, shares plunged 30% due to weak guidance and market trends.